The overall finding of the 2021 survey is that while there have not been massive shifts since 2019, and despite the impact of the COVID-19 pandemic experience, there is stronger support for genetic modification generally at 39% of high support in 2021, up from 33% in 2019.
Details of OGTR monitoring and compliance activities during the quarter ended 30 September 2021.
Clinical trial with a genetically modified human adenovirus COVID-19 vaccine
This Communiqué covers matters considered at the 27th video conference of the Gene Technology Technical Advisory Committee (28 September 2021).
DIR 155, DIR 139, DIR 138 and DIR 127 annual reports.
DIR157, DIR145, DIR143, DIR 124, DIR 118, DIR 091, DIR 066 and DIR 062 annual reports.
The Regulator commissioned a report to provide advice on genetically modified organisms (GMOs) (crops) containing multiple herbicide tolerant traits and impacts on herbicide use, herbicide tolerance and herbicide resistance management issues in Australia.
The Regulator commissioned a report to provide advice on genetically modified organisms (GMOs) (crops) containing multiple herbicide tolerant traits and impacts on herbicide use, herbicide tolerance and herbicide resistance management issues in Australia.
Clinical trial with genetically modified E.coli to reduce antibiotic resistance